Basics Harrow Health, Inc. Common Stock IPO Date: October 1, 2007 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $1.51B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 2.73% Avg Daily Range (30 D): $1.26 | 2.97% Avg Daily Range (90 D): $0.94 | 2.47% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .75M Avg Daily Volume (90 D): .54M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 50 Institutional Trades Total Inst.Trades: 685 Avg Inst. Trade: $1.75M Avg Inst. Trade (30 D): $1.88M Avg Inst. Trade (90 D): $1.7M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.92M Avg Closing Trade (30 D): $2.57M Avg Closing Trade (90 D): $2M Avg Closing Volume: 74.43K     News Sep 26, 2025 @ 12:57 PM Could Harrow's New Sedation Pill Change Millions O... Source: Triveni Kothapalli Sep 26, 2025 @ 11:00 AM Harrow to Acquire Melt Pharmaceuticals Source: Not Specified Sep 8, 2025 @ 9:57 PM Harrow Announces Pricing of $250.0 Million Offerin... Source: Mike Biega Sep 8, 2025 @ 12:00 PM Harrow Announces Offering of $250.0 Million Senior... Source: Mike Biega Aug 1, 2025 @ 2:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton Financials   TTM Q1 2025 Q4 2024 Basic EPS $.14 $-.5 $.19 Diluted EPS $.13 $-.5 $.19 Revenue $ 63.74M $ 47.83M $ 66.83M Gross Profit $ 47.51M $ 32.31M $ 52.7M Net Income / Loss $ 5M $ -17.78M $ 6.78M Operating Income / Loss $ 11.41M $ -11.23M $ 12.9M Cost of Revenue $ 16.23M $ 15.52M $ 14.14M Net Cash Flow $ -13.76M $ 19.48M $ -25.35M PE Ratio 298.92     Splits Feb 08, 2013:   1:5